21
Participants
Start Date
May 19, 2023
Primary Completion Date
December 12, 2023
Study Completion Date
May 2, 2024
Vapendavir
This study will measure and compare how VPV is absorbed in the blood, broken down in the body and eliminated when two 250 mg VPV tablets (500mg) are given in three different ways: A single dose, once a day, under fasted conditions (without any food); twice a day, for 7 days; and a single dose, once a day under fed conditions, after consuming a high-fat meal.
Syneos Health Miami, Miami
Lead Sponsor
Altesa Biosciences, Inc.
INDUSTRY